The Siteman Cancer Center (SCC) Administration (SCC-A) oversees all of the center?s research, clinical, and financial operations. SCC-A is led by two members of SCC?s Senior Leadership (SL): Nick Fisher, Executive Director of Research and Business Administration, and Christina Longnecker, Vice President of Oncology Services. Both Fisher and Longnecker have a direct reporting line and access to the SCC Director, Timothy Eberlein. Together, this administration team ensures critical connections between all research (Fisher) and clinical (Longnecker) areas within SCC, as well as coordination across satellite, network, and collaborative partners. Their close collaboration and interaction ensures that all SCC initiatives are well integrated and serve the scientific goals of the center and its two parent institutions, Washington University School of Medicine and Barnes-Jewish Hospital. As Executive Director, Fisher?s primary responsibilities include leading all SCC research functions; providing executive administrative leadership to the Director, SL, as well as program and shared resource leaders in all aspects of CCSG and SCC operations; serving on all key SCC committees, including all SL sub-committees and oncology strategic planning working groups; and assisting in the recruitment of new faculty and new SCC members. Fisher is supported by a large, talented team. Together, they provide the necessary organizational infrastructure to comply with NCI reporting requirements, meet the expectations of SL and individual faculty, support SCC?s vision and strategic plan, and oversee institutional initiatives. The SCC-A leadership team has extensive knowledge, with nearly 70 combined years of experience in research and CCSG administration, facility/resource management, clinical research, community outreach, informatics, and financial operations. Moving forward, Fisher will continue to lead the SCC-A team in maintaining an adaptive organizational infrastructure that supports SCC members in scientific discovery, aligns with overarching national CCSG goals, and engages key stakeholders in priority-setting and problem-solving.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA091842-19
Application #
10021361
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-07-01
Budget End
2025-06-30
Support Year
19
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Andley, Usha P; Tycksen, Eric; McGlasson-Naumann, Brittney N et al. (2018) Probing the changes in gene expression due to ?-crystallin mutations in mouse models of hereditary human cataract. PLoS One 13:e0190817
Sáenz, José B; Mills, Jason C (2018) Acid and the basis for cellular plasticity and reprogramming in gastric repair and cancer. Nat Rev Gastroenterol Hepatol 15:257-273
Groves, Andrew P; Gettinger, Katie; Druley, Todd E et al. (2018) Special Therapy and Psychosocial Needs Identified in a Multidisciplinary Cancer Predisposition Syndrome Clinic. J Pediatr Hematol Oncol :
Ostrander, Elizabeth L; Koh, Won Kyun; Mallaney, Cates et al. (2018) The GNASR201C mutation associated with clonal hematopoiesis supports transplantable hematopoietic stem cell activity. Exp Hematol 57:14-20
Jeong, Mira; Park, Hyun Jung; Celik, Hamza et al. (2018) Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo. Cell Rep 23:1-10
Miller, Christopher A; Tricarico, Christopher; Skidmore, Zachary L et al. (2018) A case of acute myeloid leukemia with promyelocytic features characterized by expression of a novel RARG-CPSF6 fusion. Blood Adv 2:1295-1299
Copper, Tara Conway; Jeffe, Donna B; Ahmad, Fahd A et al. (2018) Emergency Information Forms for Children With Medical Complexity: A Qualitative Study. Pediatr Emerg Care :
Stephens, Calvin J; Kashentseva, Elena; Everett, William et al. (2018) Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR/Cas9. Gene Ther 25:139-156
Trissal, Maria C; Wong, Terrence N; Yao, Juo-Chin et al. (2018) MIR142 Loss-of-Function Mutations Derepress ASH1L to Increase HOXA Gene Expression and Promote Leukemogenesis. Cancer Res 78:3510-3521
McGill, Bryan E; Barve, Ruteja A; Maloney, Susan E et al. (2018) Abnormal Microglia and Enhanced Inflammation-Related Gene Transcription in Mice with Conditional Deletion of Ctcf in Camk2a-Cre-Expressing Neurons. J Neurosci 38:200-219

Showing the most recent 10 out of 1244 publications